Autoinjectors market expected to reach $28.42 billion by 2032 with growth led by diabetes segment.

From GlobeNewswire: 2025-04-10 09:40:00

Autoinjectors market valued at $8.42 billion in 2023, projected to reach $28.42 billion by 2032 with a CAGR of 14.5%. Growth driven by demand for self-injection devices and prevalence of chronic diseases like diabetes and multiple sclerosis.

United States experiencing significant growth in autoinjectors market due to healthcare sector demand for injectable drugs and patient-friendly options for managing chronic diseases.

Disposable autoinjectors dominate industry due to ease of use and convenience, while reusable autoinjectors segment is predicted to be the fastest-growing. Diabetes segment leads market, while multiple sclerosis segment shows rapid growth.

Homecare settings account for largest revenue share, but clinics and hospitals segment expected to grow rapidly as more healthcare facilities adopt autoinjectors for drug delivery.

North America leads autoinjectors market in 2023, with U.S. driving growth due to high incidence of chronic diseases. Asia-Pacific forecasted to have highest growth, with China and India showing development in healthcare infrastructure and increasing demand for effective drug delivery systems.

Recent developments include Kindeva Drug Delivery securing contract worth up to $129 million to supply DuoDote autoinjectors, and Amneal Pharmaceuticals resubmitting NDA to FDA. In August 2024, Eli Lilly and Co. introduced a new insulin autoinjector for diabetes patients, offering faster and more convenient delivery. In October 2024, Teva Pharmaceuticals launched a DHE autoinjector for migraines, while Sandoz debuted a rheumatoid arthritis autoinjector with enhanced safety features in June 2024. Biogen also unveiled an improved multiple sclerosis autoinjector in March 2024.

Statistical data from 2023 shows a global prevalence of 537 million people with diabetes, driving demand for autoinjectors. North America had the highest prescription rates, accounting for over 40% of global prescriptions. The region also held the largest market share in device volume, representing 35% of total global units. Additionally, North America accounted for 48% of global healthcare spending.

For more information and detailed analysis of the autoinjectors market from 2024-2032, visit the link provided. SNS Insider is a leading market research agency providing valuable insights and data to help clients make informed decisions in a rapidly changing environment. Contact [email protected] for customized research needs.



Read more at GlobeNewswire: Autoinjectors Market Size to Hit USD 28.42 Billion by 2032,